Viewing Study NCT05338892


Ignite Creation Date: 2025-12-24 @ 3:30 PM
Ignite Modification Date: 2026-01-19 @ 5:29 PM
Study NCT ID: NCT05338892
Status: COMPLETED
Last Update Posted: 2023-10-19
First Post: 2022-04-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Sponsor: Regeneron Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: R1979-ONC-2090
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators